The detailed information for PTAB case with proceeding number IPR2025-00283 filed by Ajinomoto Co., Inc. against AbTis Co., Ltd. on Dec 24, 2024. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2025-00283
Filing Date
Dec 24, 2024
Petitioner
Ajinomoto Co., Inc.
Respondent
AbTis Co., Ltd.
Status
Pending
Respondent Application Number
18154998
Respondent Tech Center
1600
Respondent Patent Number
11896675

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.


Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Director Discretionary Decision: Refer

Jul 2, 2025PAPERBOARD

Opposition to Patent Owner’s Argument for Discretionary Denial

Jun 11, 2025PAPERPETITIONER

Patent Owner's Motion for Withdrawal and Substitution of Counsel

May 14, 2025PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

May 14, 2025PAPERPATENT OWNER

Patent Owner's Argument for Discretionary Denial

May 12, 2025PAPERPATENT OWNER

Ex. 2001 - Statutory Disclaimer of U.S. Patent No. 11,896,675

May 12, 2025EXHIBITPATENT OWNER

Patent Owner's Preliminary Response

May 12, 2025PAPERPATENT OWNER

Notice: Extending Deadline for Discretion Briefing

Apr 10, 2025PAPERBOARD

Patent Owner's Updated Power of Attorney

Apr 3, 2025PAPERPATENT OWNER

Patent Owner's Updated Mandatory Notices

Apr 3, 2025PAPERPATENT OWNER

NOTICE OF FILING DATE ACCORDED TO PETITION AND TIME FOR FILING PATENT OWNER PRELIMINARY RESPONSE

Feb 12, 2025PAPERBOARD

Notice: Mandatory Notice

Jan 14, 2025PAPERPATENT OWNER

U.S. Patent No. 11,896,675 (the ’675 patent)

Dec 24, 2024EXHIBITPETITIONER

Yamada et al., Dev. a Novel Chemical Site-Specific Conjugation Poster

Dec 24, 2024EXHIBITPETITIONER

Okuzumi, Technology of Site Specific Conjugation (PepTalk Presentation)

Dec 24, 2024EXHIBITPETITIONER

WO 2018/199337 (Yamada)

Dec 24, 2024EXHIBITPETITIONER

WO 2019/240288 (Matsuda)

Dec 24, 2024EXHIBITPETITIONER

Clarivate Analytics, PepTalk 2019 - CHI's 18th Annual Meeting

Dec 24, 2024EXHIBITPETITIONER

PepTalk 2019 Conference Program

Dec 24, 2024EXHIBITPETITIONER

Croasdell, 18th Annual PepTalk: DRUGS OF THE FUTURE

Dec 24, 2024EXHIBITPETITIONER

Photographs from Luncheon Presentation

Dec 24, 2024EXHIBITPETITIONER

Photographs from Poster Presentation

Dec 24, 2024EXHIBITPETITIONER

Email exch. with Dr. Igor D'Angelo providing copy of PepTalk Presentation

Dec 24, 2024EXHIBITPETITIONER

Email exch. Dr. Bernhard Valldorf providing a copy of PepTalk Presentation

Dec 24, 2024EXHIBITPETITIONER

Email exch. Dr. Michael Szardenings providing copy of PepTalk Presentation

Dec 24, 2024EXHIBITPETITIONER

Email exchange with Susan Lee providing a copy of PepTalk Presentation

Dec 24, 2024EXHIBITPETITIONER

Email exch. Professor Rolf G. Werner providing copy of PepTalk Presentation

Dec 24, 2024EXHIBITPETITIONER

LinkedIn profile of Dr. Igor D'Angelo

Dec 24, 2024EXHIBITPETITIONER

LinkedIn profile of Dr. Bernhard Valldorf

Dec 24, 2024EXHIBITPETITIONER

LinkedIn profile of Dr. Michael Szardenings

Dec 24, 2024EXHIBITPETITIONER

LinkedIn profile of Susan Lee

Dec 24, 2024EXHIBITPETITIONER

Lambert and Berkenblit, Antibody–Drug Conjugates for Cancer Treatment

Dec 24, 2024EXHIBITPETITIONER

Birrer et al. Antibody-Drug Conjugate-Based Therap.: State of the Science

Dec 24, 2024EXHIBITPETITIONER

Schumacher et al., Current Status: Site-Specific Antibody Drug Conjugates

Dec 24, 2024EXHIBITPETITIONER

Nejadmoghaddam et al. Antibody-Drug Conjugates Possibilities and Challenges

Dec 24, 2024EXHIBITPETITIONER

9th Annual World ADC Conference Program, November 12-15, 2018

Dec 24, 2024EXHIBITPETITIONER

Mendelsohn, Technology of Site Specific Conjugation for Next Generation ADC

Dec 24, 2024EXHIBITPETITIONER

Oxford English Dictionary definition of “terminal”

Dec 24, 2024EXHIBITPETITIONER

Tam et al. Functional, Biophysical and Structural Characterization of Human

Dec 24, 2024EXHIBITPETITIONER

Lu et al. Beyond binding antibody effector functions in infectious diseases

Dec 24, 2024EXHIBITPETITIONER

Prosecution History for U.S. Patent No. 11,896,675 (the ’675 patent)

Dec 24, 2024EXHIBITPETITIONER

Amblard et al. The CuI-catalyzed Huisgen 1,3-dipolar cycloaddition of azide

Dec 24, 2024EXHIBITPETITIONER

U.S. 2023/0158167 U.S. pre-grant publication of U.S. Application 16/980,503

Dec 24, 2024EXHIBITPETITIONER

WO 2020/184944

Dec 24, 2024EXHIBITPETITIONER

U.S. 2023/0158167 (U.S. National Stage of WO 2020/184944)

Dec 24, 2024EXHIBITPETITIONER

Declaration of Dr. Tatsuya Okuzumi

Dec 24, 2024EXHIBITPETITIONER

Japanese Patent Application No. 2018-113962

Dec 24, 2024EXHIBITPETITIONER

Petitioner's Power of Attorney

Dec 24, 2024PAPERPETITIONER

Declaration of Dr. Lawrence Nathan Tumey

Dec 24, 2024EXHIBITPETITIONER

U.S. 2020/0190165 (U.S. National Stage of Yamada)

Dec 24, 2024EXHIBITPETITIONER

U.S. 2021/0139541 (U.S. National Stage of Matsuda)

Dec 24, 2024EXHIBITPETITIONER

Verified English Translation of Japanese Pat. App. No. 2018-113962

Dec 24, 2024EXHIBITPETITIONER

Verified English translation of application US Ser. No. 62/815,557

Dec 24, 2024EXHIBITPETITIONER

Petition For Inter Partes Review

Dec 24, 2024PAPERPETITIONER